Application Sponsors
ANDA 214549 | TEVA PHARMS USA INC | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Application Products
001 | TABLET;ORAL | 250MG | 0 | ERYTHROMYCIN | ERYTHROMYCIN |
002 | TABLET;ORAL | 500MG | 0 | ERYTHROMYCIN | ERYTHROMYCIN |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2021-02-11 | STANDARD |
Submissions Property Types
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
CDER Filings
TEVA PHARMS USA INC
cder:Array
(
[0] => Array
(
[ApplNo] => 214549
[companyName] => TEVA PHARMS USA INC
[docInserts] => ["",""]
[products] => [{"drugName":"ERYTHROMYCIN","activeIngredients":"ERYTHROMYCIN","strength":"250MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ERYTHROMYCIN","activeIngredients":"ERYTHROMYCIN","strength":"500MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"02\/11\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2021-02-11
)
)